RECURSION PHARMACEUTICALS, INC.
RXRX
23 insider filings · Latest: May 7, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | May 8 8:59 PM | Christopher GibsonDirector | Sale | 40,000 | $3.37 | $134.8K | 926,556(D) | View → |
| May 5, 2026 | May 7 8:44 PM | Blake BorgesonDirector | Sale | 30,000 | $3.52 | $105.6K | 6,199,863(D) | View → |
| May 7, 2026 | May 7 3:13 PM | Gibson Christopher | Proposed Sale | 40,000 | $3.37 | $134.8K | — | View → |
| May 5, 2026 | May 5 2:22 PM | Borgeson Blake | Proposed Sale | 30,000 | $3.52 | $105.6K | — | View → |
| Apr 22, 2026 | Apr 24 8:23 PM | Christopher GibsonDirector | Sale | 40,000 | $3.61 | $144.4K | 906,556(D) | View → |
| Apr 22, 2026 | Apr 22 1:47 PM | Gibson Christopher | Proposed Sale | 40,000 | $3.61 | $144.4K | — | View → |
| Apr 7, 2026 | Apr 8 8:58 PM | Christopher GibsonDirector | Sale | 40,000 | $3.10 | $124.0K | 906,556(D) | View → |
| Apr 7, 2026 | Apr 8 8:58 PM | Blake BorgesonDirector | Sale | 30,000 | $3.10 | $93.0K | 6,229,863(D) | View → |
| Apr 7, 2026 | Apr 7 2:46 PM | Gibson Christopher | Proposed Sale | 40,000 | $3.10 | $124.0K | — | View → |
| Apr 7, 2026 | Apr 7 2:17 PM | Borgeson Blake | Proposed Sale | 30,000 | $3.10 | $93.0K | — | View → |
| Mar 23, 2026 | Mar 25 8:36 PM | Christopher GibsonDirector | Sale | 40,000 | $3.25 | $130.0K | 906,556(D) | View → |
| Mar 23, 2026 | Mar 23 2:49 PM | Gibson Christopher | Proposed Sale | 40,000 | $3.25 | $130.0K | — | View → |
| Mar 17, 2026 | Mar 18 9:52 PM | Ben R TaylorChief Financial Officer | Sale | 7,956 | $3.39 | $27.0K | 1,180,318(D) | View → |
| Mar 17, 2026 | Mar 17 2:53 PM | Taylor Ben R | Proposed Sale | 7,956 | $3.39 | $27.0K | — | View → |
| Mar 9, 2026 | Mar 11 9:41 PM | Najat KhanDirector, CEO and President | Sale | 28,298 | $3.35 | $94.7K | 2,262,085(D) | View → |
| Mar 9, 2026 | Mar 9 5:45 PM | Najat Khan | Proposed Sale | 28,298 | $3.35 | $94.7K | — | View → |
| Mar 3, 2026 | Mar 4 9:38 PM | Blake BorgesonDirector | Sale | 170,000 | $3.46 | $588.2K | 6,259,863(D) | View → |
| Mar 3, 2026 | Mar 3 5:45 PM | Borgeson Blake | Proposed Sale | 170,000 | $3.46 | $588.2K | — | View → |
| Feb 19, 2026 | Feb 20 12:30 AM | Christopher GibsonDirector | Sale | 40,000 | $3.46 | $138.4K | 906,556(D) | View → |
| Feb 18, 2026 | Feb 20 12:30 AM | Ben R TaylorChief Financial Officer | Sale | 13,426 | $3.08 | $41.4K | 1,195,349(D) | View → |
Page 1 of 5
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 7, 2026 | May 8 8:59 PM | Christopher GibsonDirector | Conversion | 60,000 | — | 4,343,334(D) | View → |
| Apr 22, 2026 | Apr 24 8:23 PM | Christopher GibsonDirector | Conversion | 40,000 | — | 4,403,334(D) | View → |
| Apr 7, 2026 | Apr 8 8:58 PM | Christopher GibsonDirector | Conversion | 40,000 | — | 4,443,334(D) | View → |
| Mar 23, 2026 | Mar 25 8:36 PM | Christopher GibsonDirector | Conversion | 40,000 | — | 4,483,334(D) | View → |
| Mar 9, 2026 | Mar 11 9:41 PM | Christopher GibsonDirector | Conversion | 20,000 | — | 4,523,334(D) | View → |
| Feb 19, 2026 | Feb 20 12:30 AM | Christopher GibsonDirector | Conversion | 40,000 | — | 4,543,334(D) | View → |
| Feb 4, 2026 | Feb 6 10:53 PM | Christopher GibsonDirector | Conversion | 40,000 | — | 4,583,334(D) | View → |
| Jan 20, 2026 | Jan 23 12:34 AM | Christopher GibsonDirector | Conversion | 40,000 | — | 4,623,334(D) | View → |